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Article
Introduction
According to the World Cancer Report 2015, there will be 
21.7 million expected new cancer cases and 13 million pre-
dicted cancer deaths by 2030.1 At the same time, there is a 
growing population of survivors as a result of more effec-
tive cancer treatments.1 Cancer-related fatigue (CRF) is one 
of the most common and distressing symptoms in cancer 
patients regardless of tumor and treatment type.2,3 Although 
there is no clear consensus regarding the definition of CRF,4 
the National Comprehensive Cancer Network (NCCN) pro-
vides one of the most commonly used descriptions: CRF is 
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Abstract
Background: Although cancer-related fatigue (CRF) has gained increased attention in the past decade, it remains difficult 
to treat. An integrative approach combining conventional and complementary medicine interventions seems highly promising. 
Treatment programs are more likely to be effective if the needs and interests of the people involved are well represented. 
This can be achieved through stakeholder engagement. Objectives: The aim of the study was to develop an integrative CRF 
treatment program using stakeholder engagement and to compare it to an expert version. Method: In a qualitative study, a 
total of 22 stakeholders (4 oncologists, 1 radiation-oncologist, 1 psycho-oncologist, 5 nurses/nurse experts, 9 patients, 1 patient 
family member, 1 representative of a local Swiss Cancer League) were interviewed either face-to-face or in a focus group setting. 
For data analysis, qualitative content analysis was used. Results: With stakeholder engagement, the integrative CRF treatment 
program was adapted to usual care using a prioritizing approach and allowing more patient choice. Unlike the expert version, 
in which all intervention options were on the same level, the stakeholder engagement process resulted in a program with 3 
different levels. The first level includes mandatory nonpharmacological interventions, the second includes nonpharmacological 
choice-based interventions, and the third includes pharmacological interventions for severe CRF. The resulting stakeholder based 
integrative CRF treatment program was implemented as clinical practice guideline at our clinic (Institute for Complementary and 
Integrative Medicine, University Hospital Zurich). Conclusion: Through the stakeholder engagement approach, we integrated 
the needs and preferences of people who are directly affected by CRF. This resulted in an integrative CRF treatment program 
with graded recommendations for interventions and therefore potentially greater sustainability in a usual care setting.
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“a distressing, persistent, subjective sense of physical, emo-
tional and/or cognitive tiredness or exhaustion related to 
cancer or cancer treatment that is not proportional to recent 
activity and interferes with usual functioning.”5 Moreover, 
up to 95% of cancer patients experience CRF during che-
motherapy or radiotherapy6 and face a high risk of experi-
encing CRF in the posttreatment phase7. CRF has been 
associated with shorter survival8,9 and a significant decrease 
in overall quality of life.10 Additional consequences are sig-
nificant health care costs, staying off work or sick leave and 
lost earnings and productivity.11-16
At present, CRF is often undetected and untreated in 
many cancer patients.4 This might be because patients are 
often focusing on survival; consequently, they consider 
fatigue symptoms as an inescapable side effect of cancer 
therapy and therefore do not report them to their health care 
providers. Furthermore, lack of awareness and time pres-
sure on health care providers may prevent them from detect-
ing CRF symptoms.17-19 Moreover, limited energy and 
mobility are obstacles in making additional physician’s 
appointments that could unmask CRF symptoms.20
CRF is complex and has multiple causes. It is difficult to 
distinguish between the causative, intensifying and mainte-
nance factors, which can manifest on different levels, such as 
on somatic, emotional, or cognitive level, in a given patient. 
Consequently, a careful differential diagnosis is needed when 
a cancer patient reports fatigue symptoms.5,21,22
After CRF is diagnosed, complex, non-pharmacological 
interventions are usually applied.5 In particular, psychoso-
cial interventions and exercise can reduce CRF during can-
cer treatments.5,23,24 In addition, approximately 40% of 
cancer patients use complementary medicine (CM) inter-
ventions.25 In 2016, the NCCN provided an overview of the 
evidence regarding CM treatments for CRF, which the net-
work integrated into its guidelines; the included CM treat-
ments are yoga, bright white light therapy, and 
mindfulness-based stress reduction.5 Furthermore, the 
results of randomized controlled trials suggest that other 
CM interventions—namely, acupuncture, acupressure, gin-
seng, guarana, and qigong—may reduce CRF.5,26 However, 
because of its complexity, CRF remains difficult to treat, 
and a multimodal treatment program is required. An inte-
grative approach that combines conventional and CM inter-
ventions, considers patients’ needs and preferences and 
provides opportunities for self-care seems highly promis-
ing. In addition, effects, possible side effects and interac-
tions can be better monitored with an integrative approach.
Treatment programs are more likely to be effective if the 
needs, values, and interests of the people involved are con-
sidered.27-29 This can be achieved with stakeholder engage-
ment. In the medical field, stakeholder engagement means 
engaging, for example, patients and their caregivers, 
patients’ family members, and health care providers but 
also other stakeholders, such as patient advocacy and sup-
port groups, research funding agencies, cancer leagues, and 
other funders of medical care. Surroundings, such as infra-
structures, and context factors (eg, political environments) 
are also considered. In short, everyone affected by and 
involved with a specific topic can provide input.27-29
Including stakeholder engagement in the research pro-
cess increases the chance that the topic of a study addresses 
the questions and needs of the stakeholders and that the 
results will contribute to improved practices.26,28,30,31 
Patients suffering from CRF are dealing with complex 
interactions among the symptoms, effects and side effects 
of the disease and its different treatments. The subjective 
experience of these complex relationships can only be ade-
quately reported by the patients themselves and by those 
who are directly affected by it.30 Therefore, developing a 
coherent treatment program that combines CM interven-
tions with conventional therapies for CRF requires the 
knowledge and integration of the stakeholder’s experiences, 
needs, and values.
The aim of this study was to develop an integrative CRF 
treatment program using stakeholder engagement and com-
paring it with an expert version of the program.
Methods
We used a stepwise approach to develop the final stake-
holder version of the CRF treatment program (Figure 1).
We started with the development of a literature- and evi-
dence-based expert version of an integrative CRF treatment 
program. To develop the stakeholder version of the treat-
ment program, we conducted qualitative face-to-face and 
focus group interviews with the stakeholders. The results 
from the interviews were presented to the stakeholder advi-
sory board, and a consensus was developed. The stake-
holder treatment program was finalized in written Delphi 
rounds and compared with the expert version.
The project was approved by the ethics committee of 
Zurich (KEK-ZH-Nr. 2014-0689), Switzerland, in March 
2015 and was conducted accordingly. All the participants 
provided written informed consent.
Stakeholder Engagement
We involved different stakeholders (oncologists, a radiation 
oncologist, a psycho-oncologist, nurses, nurse experts, a rep-
resentative of a local Swiss Cancer League [an expert consul-
tant in cancer survivorship], patients, and a patient’s family 
member) to learn about their experiences and needs concern-
ing CRF and to gather their opinions and suggestions on the 
expert version of the integrative CRF treatment program.
In addition, we formed a stakeholder advisory board 
consisting of 1 patient, 2 oncologists, 1 radiation oncolo-
gist, 1 psycho-oncologist, 1 nurse expert, and 1 represen-
tative from one of the local Swiss Cancer Leagues (an 
expert consultant in cancer survivorship). The members of 
the advisory board not only represented the different 
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stakeholder groups involved in the project but were also 
very experienced with CRF.
The stakeholders were mainly recruited from within the 
University Hospital Zurich according to the principles of “the-
oretical sampling.”32 The health care providers represented 
the hospital’s main oncology departments, whereas the 
patients came mostly from our clinic (Institute for 
Complementary and Integrative Medicine, University 
Hospital Zurich). To complete the sample and ensure that we 
obtained different experiences with and perspectives on CRF, 
some stakeholders (eg, the patient family member, the repre-
sentative from a local Swiss Cancer League and a nurse expert 
specialized in CRF) were recruited from outside the clinic.
Qualitative Data Collection and Analysis
Data collection and analysis followed the principles and 
methods of qualitative content analysis.33-35 We used quali-
tative content analysis to focus on the whole spectrum of 
topics and viewpoints (eg, in contrast to discourse analysis, 
Figure 1. From the expert version to the stakeholder version of the cancer-related fatigue (CRF) treatment program.
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Table 1. Sample Patients: Cancer Characteristics.
Cancer 
Characteristics Specification Number
Diagnosis Anal 1
Breast 3
Colon 1
Gastrointestinal stromal tumor 1
Prostate cancer 1
Lymphoma 2
 Aggressive non-Hodgkin’s lymphoma (1)
 Hodgkin disease (1)
Years since 
diagnosis
≥9 1
3-4 3
1-2 4
≤ 1 1
Treatment Surgery 6
Chemotherapy 7
Radiation therapy 5
Hormonal therapy 2
Immunotherapy 1
Targeted therapy 1
Metastasis Yes (liver) 1
No 8
Tumor recurrence Yes 1
No 8
Previous cancer Yes, Hodgkin disease (1986), osteoma (2006) 2
No 7
which focuses more the ongoing of a discussion) that the 
interviewees brought up regarding the experiences and 
needs with CRF. As a first step, the stakeholders were inter-
viewed either face-to-face or in a focus group setting.33-35 
The qualitative interviews were semistructured and lasted 
approximately 90 minutes. They consisted of 2 main parts. 
In the first part, the stakeholders were asked open questions 
about their experiences and needs concerning CRF treat-
ment (patients) or about their opinions regarding the treat-
ment options for CRF (other stakeholders) of which they 
are aware. In the second part, the stakeholders were asked 
to evaluate the expert version of the integrative CRF treat-
ment program. All the interviews were audio recorded.
As the second step, 2 researchers from our clinic 
(Institute for Complementary and Integrative Medicine, 
University Hospital Zurich) independently summarized 
the main topics that the stakeholders brought up by listen-
ing to the audiotaped interviews. They validated their 
results intersubjectively in a discussion and merged them 
in a separate summary. In addition, based on their valida-
tion, the transcription and coding order was determined. 
This process corresponds to the “video club” approach, 
which has its origin in education research.36 In this 
approach, teachers discuss their videotaped lessons in 
groups to improve their teaching. The basic assumption 
behind a video club is that the members gain a more pro-
found and informed understanding of the data by dealing 
with real-time data and discussing their perceptions and 
interpretations with each other.
In the next step, the audio-recorded interviews were 
transcribed.37,38 The same 2 researchers inductively built a 
thematic code system for the data according to the princi-
ples of grounded theory’s “constant comparison 
method.”32,39 The data were then coded in sense units using 
the qualitative data analysis software MAXQDA, Version 
11.1.2. The coding was interchangeably validated by the 2 
researchers and then analyzed in relation to the further 
development of the expert version of the integrative CRF 
treatment program.
Results
Sample
In total, 22 stakeholders (13 women, 9 men) were inter-
viewed, resulting in approximately 21 hours of audio data. 
The involved stakeholders were 9 patients and 13 other (4 
oncologists, 1 radiation oncologist, 1 psycho-oncologist, 5 
nurses/nurse experts, 1 representative of a local Swiss 
Cancer League and 1 patient’s family member).
With the patients (9 in total, 7 women, 2 men; mean age 
of 55 years, range 35-65 years), we conducted 2 face-to-
face interviews and 1 focus group consisting of 7 partici-
pants (Table 1).
The average time span between the patients’ cancer diag-
noses and their CRF diagnoses was 10 months. During the 
project, we confirmed the CRF diagnosis of the participating 
patients using a numeric rating scale with 2 questions.22 First, 
the patients rated the intensity of fatigue within the past week 
on a scale from 0, no fatigue, to 10, the most severe fatigue 
imaginable (question 1). Second, the patients were asked to 
rate how their fatigue affected their daily life during the past 
week using a similar 0-to-10 scale (question 2). Generally, if 
the intensity was rated 4 or higher for the first question and 5 
or higher for the second, further diagnostics should be consid-
ered. The patients showed an average score of 5.1 (range 2-8) 
for question 1 and 4.6 (range 0-9) for question 2. All the 
patients had either completed or were undergoing standard 
cancer therapy and had previously used CM treatments.
With the other stakeholders (6 women, 7 men; mean age 
of 45 years, range 31-62 years), we conducted 10 face-to-
face interviews and 1 focus group consisting of 3 nurses and 
nurse experts. The interviewed health care providers esti-
mated that approximately 57% (range 10%-100%) of their 
cancer patients suffer from CRF.
The stakeholder advisory board included a subset of the 
22 stakeholders. With the exception of the interviewer and 
the principal investigator (CC and CMW), the individual 
board members were interviewed face-to-face as stakehold-
ers, independent of the advisory board meeting.
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Expert Version of the Integrative CRF Treatment 
Program
The expert version of the integrative CRF treatment pro-
gram 26 was derived from the available scientific evidence.26 
It introduces individual interventions as treatment options 
on the same level and presents the possibility of combining 
2 or more of them if needed (Table 2).
During psychoeducational intervention, patients are 
informed about CRF, and then specific topics such as activ-
ity and rest, sleep in general, possible comorbidities such as 
depression or anxiety, and new opportunities and limits 
under CRF are discussed.40 This intervention is usually pro-
vided by psycho-oncologists.
Patients are encouraged to participate in the whole 
treatment program, which consists of different interven-
tions.41 One intervention encourages patients to improve 
endurance and strength by choosing a form of exercise 
that they enjoy.42,43 Another intervention consists of mind 
body medicine techniques, which include classic relax-
ation techniques such as autogenic training or progressive 
muscle relaxation, and mindfulness-based approaches 
such as mindfulness meditation, yoga, or qigong.44-47 
Patients may also benefit from a total of 6 weekly indi-
vidual acupuncture treatments based on traditional 
Chinese medicine.48,49 Moreover, patients are theoretically 
and practically introduced to acupressure, including 5 
points that have a relaxing effect: heart 7, liver 3, spleen 6, 
anmian, and yintang.50 The points should be stimulated 
daily for 3 minutes each (the first 4 points on both sides of 
the body and yintang as a single point). The patients also 
receive a handout describing acupressure concepts so that 
they can practice at home after the encounter with the spe-
cialist. There are also several drugs available to treat CRF, 
including methylphenidate, modafenil, corticosteroids, 
ginseng, and guarana.51-56 Patients are introduced to their 
modes of action, side effects, and effectiveness and explore 
what types of medication could be useful for their specific 
condition.
General Needs Regarding an Integrative CRF 
Treatment Program
The stakeholders (all the terms in quotation marks indicate 
original quotes from the interviews with the stakeholders) 
indicated a need for patient orientation and agreed that 
strengthening “autonomy” and “self-determination” was an 
overall goal of CRF treatment. In their opinion, patient ori-
entation in CRF treatment would also involve creating a 
“drop-in center” that “coordinates” and “monitors” and 
“where there is time to answer patients’ questions” and that 
is “geographically a comfortable distance” from patients. In 
this context, the stakeholders also called for stronger inter-
disciplinary cooperation among all involved health care 
providers. Moreover, the patients expressed their wish to be 
“closely supported” and “accompanied” both during ther-
apy and after active treatment ends. The patients reported 
having suffered from substantial fatigue that restricted their 
activities of daily living and work and said that they often 
felt “left alone”, particularly after the active cancer treat-
ment period had ended. Consequently, they would have 
liked “more frequent aftercare”. The nurses suggested that 
in such an environment, they could provide a “hinge-like 
function” if they were adequately empowered. Many stake-
holders would welcome “applying a standard diagnostic 
tool for CRF” rather than being presented with numerous 
different tools that lack uniformity and validation.
Overall Opinion Regarding the Expert Version of 
the Integrative CRF Treatment Program
In general, the interviewed stakeholders thought that CRF 
should be addressed preventatively immediately after the 
cancer diagnosis. The stakeholder advisory board further 
discussed what information should be given at what time 
point and concluded that patients should be informed soon 
after diagnosis but not during the initial consultation imme-
diately after diagnosis because at that appointment, patients 
usually are overwhelmed and have a hard time processing 
all the information they receive. The advisory board would 
prefer the creation of an online information tool about CRF 
for the cancer patients.
According to the stakeholders, self-care options should be 
at the center of the interventions, motivating patients to be 
active and to regain self-efficacy. The patient family member 
summarized this need as follows: “…something that you can 
do by yourself …nothing that is additionally inflicted upon 
you”. Patients and the patient family member emphasized the 
Table 2. Expert Version of the Integrative Cancer-Related 
Fatigue (CRF) Treatment Program Before Stakeholder 
Engagement.
Process Intervention Focus
Use one 
or more 
treatments
Psychoeducation Activity and rest, sleep, 
opportunities, and limits
Exercise Endurance, strength, fun
Mind body 
medicine 
techniques
Mindfulness meditation, 
autogenic training, 
progressive muscle relaxation, 
yoga, qigong
Acupressure and 
acupuncture
Acupressure: daily as self-care
Acupuncture: 1×week, 6 
weeks
Medication Methylphenidate, modafinil, 
corticosteroid, ginseng, 
guarana
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importance of being active themselves but also noted they 
often lack important information about CRF. The nurses in 
particular, but also other stakeholders, stressed that the treat-
ment program should be individualized and should consider 
the personal resources, interests and cultural and social back-
ground of the patients before their cancer diagnosis. In the 
stakeholders’ opinion, the treatment program will be better 
integrated into patients’ everyday lives if it fully considers 
the patient as an individual.
The stakeholder advisory board suggested the widespread 
use of the CRF treatment program but assumed that the pro-
gram would be more attractive to patients who are “open to 
CM”, such as those who are “young”, more “active” and have 
an “awareness of self-care”. For the “average cancer patient” 
who is “older than 65”, “inactive, with “no awareness of self-
care” and suffering from “comorbidities”, the CRF treatment 
program would require a “complete change of lifestyle” that 
would be very difficult to achieve in the context of CRF. 
Consequently, the board members discussed whether a target 
group should be defined for the proposed treatment program. 
As they wished for the program to experience widespread use, 
they suggested screening all cancer patients for CRF and then 
following in a patient-oriented manner rather than defining a 
target group.
Introducing Levels and Prioritizing Treatments
The health care providers and the patient family member 
called for “prioritizing the different treatment options in the 
program” to provide clearer guidance and to take into 
account the exhaustion and tiredness of the CRF patients, 
which could make fewer interventions be more feasible. In 
comparison, the patients pointed to the importance of 
patient orientation, “adjusting the treatment to the individ-
ual” and “his or her everyday situation”. The nurses added 
the importance of also considering the patient’s “social and 
cultural background”. Briefly, the stakeholders stressed pri-
oritizing approaches and patient orientation.
The stakeholders agreed that psychoeducation and exer-
cise should be the first priority; these approaches were consid-
ered the most effective for treating CRF, and the 2 treatments 
were deemed equally valuable. Furthermore, all stakeholders 
preferred non-pharmacological treatment options to pharma-
cological treatment options. They found mind body medicine 
techniques reasonable overall but had conflicting opinions 
regarding acupuncture. Whereas some interviewees were crit-
ical of acupuncture’s effectiveness, others reported having 
positive experiences with acupuncture.
Priorities When Starting the CRF Treatment 
Program
In terms of priorities, the stakeholders agreed on 2 interven-
tions with which the treatment program should start. First, 
patients and their family members should be informed 
about CRF soon after their cancer is diagnosed. At present, 
cancer patients are not usually systematically informed 
about CRF. Several patients commented that they had to 
“find out everything by themselves”, which was difficult 
while suffering from CRF. Additionally, the stakeholders 
stated that being informed about the existence of CRF and 
“what it means to suffer from CRF” helps patients better 
“understand”, “accept” and “cope” with the syndrome. In 
addition, “autonomy” and “self-determination” can only be 
achieved “with good-quality information”, according to the 
stakeholders.
Second, patients should start exercising soon after they 
are diagnosed with cancer. A nurse specified that “cancer 
patients in a curative and palliative condition should be dif-
ferentiated.” Based on her experience, CRF patients receiv-
ing curative treatment should be informed about CRF and 
start exercising as described above, whereas CRF patients 
receiving palliative care should “focus on coping”, for 
instance, by “setting priorities”, “managing their energy”, 
or “learning to let go.”
Stakeholders’ Thoughts About Individual 
Treatment Options
Psychoeducation and Exercise. Although the stakeholders 
stated that psychoeducation was 1 of the 2 most important 
first steps for treating CRF, they found the term itself 
problematic:
Nurse 1: At the very moment they [the patients] hear 
“psycho”, doors are closing immediately and we 
don’t need to discuss it any further…”
Nurse 2: …Could we use the popular term “empower-
ment” or “promoting self-management?” You know, 
to cancel the “psycho.” Because, I mean, we are 
health specialists. I am thinking about it as informa-
tion. However, if I’m showing it [the treatment pro-
gram] to a patient and “psychoeducation” is written 
on it—and least of all, I want to be educated as a 
patient.
Therefore, the stakeholders opted to change the term “psy-
choeducation” to avoid the stigma of suffering from a 
“mental disorder” and the implicit moral statement that the 
patient somehow needs to be educated.
Along with psychoeducation, the stakeholders consid-
ered exercise a first priority when treating CRF. The patient 
family member added that caregivers and family members 
can exercise with the patient and that this provides an 
opportunity to contribute actively to the patient’s health. 
This was very important to the interviewed patient family 
member as a means of overcoming the “helplessness” that 
the partner of a cancer patient could feel.
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Stakeholders associated regaining trust in the body and 
preserving muscle mass as important goals:
Medical doctor: What you shouldn’t underestimate in 
exercise and strength is gaining back trust in one’s own 
capacity. If they couldn’t take three steps on the stairs 
and suddenly, after one month, they manage the stairs.
Furthermore, regaining physical capacity was thematically 
linked to regaining self-efficacy:
Nurse expert: People are telling me that they cannot trust 
their own body because they suffer from cancer and 
didn’t notice it. Then, fatigue comes… and surgery, 
being disfigured, not being able to consider yourself 
beautiful anymore. So, distance from your own body. 
Sometimes, they look at themselves from the outside 
and say, “That is someone different. I do not want any-
thing to do with that”…And yes, afterwards, you 
should return to life, but it does not work out…It’s very 
important to give people back these capacities, that 
they can influence their own actions and experiences.
This nurse expert summarized what most of the stakehold-
ers reported: that patients lose their faith in their body and 
how important it is for them to regain self-efficacy. The 
interviewees believed that patients could rebuild trust in 
their body and regain self-efficacy through a combination 
of psychoeducation and exercise.
Regarding exercise, the stakeholders also highlighted 
the problem that starting to exercise while suffering from 
fatigue is difficult. The health care providers thought that 
exercising with CRF is easier for patients were physically 
active before their cancer diagnosis. They considered the 
program proposed in the expert version more realistic for 
patients with light to moderate CRF. The patients pointed to 
the difficulty of exercising during or soon after chemother-
apy because of its side effects and the resulting exhaustion. 
Some of the patients said they liked to be coached or at least 
guided during exercise:
Patient: The doctors suggest [concerning exercise] to do 
whatever feels good to you …That is something for 
the fifty-plus…I would have needed coaching.
The health care providers suggested institutionalized exer-
cise programs. The advisory board members specifically 
preferred institutionalized group programs to individual 
coaching because of better cost-effectiveness and the lim-
ited resources of the health care providers.
Mind Body Medicine Techniques. The stakeholders welcomed 
mind body medicine techniques in treating CRF. Some of 
the health care providers went into more detail and described 
mind body medicine techniques as a “way to process can-
cer” and all its side effects, including CRF; they suggested 
that these techniques could help patients “cope with the 
stress”, “the emotions”, and “the existential questions” that 
come along with suffering from cancer. A nurse described 
this effect as follows and added that mind body medicine 
techniques might carry less stigma than psychotherapy:
Nurse: …it is a way for these people [cancer patients] to 
retreat to the quiet and not try to suppress anything; it 
is a way to open oneself to emotions . . . It becomes a 
path for processing…It carries less stigma than going 
to a psychologist.
Whereas some stakeholders believed that mind body medi-
cine techniques only work when patients had already prac-
ticed them before their cancer diagnosis, other stakeholders 
reported that they had benefited from mind body tech-
niques, although not all of them had practiced them before 
their cancer diagnosis.
Acupuncture and Acupressure. The stakeholders had conflict-
ing opinions regarding acupuncture and acupressure. Some 
of the medical doctors and nurses were rather critical, stat-
ing that acupuncture and acupressure are more a “question 
of belief” than an effective therapy. A medical doctor 
explained his rejection of acupuncture in the context of his 
worldview:
Medical doctor: That you puncture some energy lines or 
whatever and points—it doesn’t fit at all into my philo-
sophical and physiological worldview. It simply doesn’t 
fit in my concept of body functions and physiology.
In addition, these stakeholders were often not convinced 
that the existing clinical trials are of good quality.
In contrast, there were stakeholders who reported expe-
riencing positive effects of acupuncture and acupressure on 
CRF, such as the following patient:
Patient: Acupuncture is—during an episode of fatigue, if 
you are really inside [the fatigue], not just at its border 
area, if you really suffer from fatigue, then acupuncture 
is awesome!…It gives me energy. I react very well to it.
Concerning acupressure, the stakeholders welcomed the 
possibility of a treatment that “can be done by the patients 
themselves at home,” allowing them to actively “contribute 
to their own well-being” and “strengthen their autonomy”. 
Two patients mentioned that practicing acupressure is not 
always easy. One patient reported that she “immediately 
falls asleep” while performing acupressure on herself and 
that she was therefore unable to execute it. The other patient 
mentioned a “lack of strength in her arms” as a result of 
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Table 3. Cancer-Related Fatigue (CRF) Treatment Program 
After Stakeholder Engagement.
Level Process Intervention Focus
1 Main treatment 
for all patients, 
including 
advice for 
implementation
Information and 
motivation
Activity and 
rest, sleep, 
opportunities, and 
limits
Exercise Endurance, 
strength, fun
2 Introduced 
as additional 
treatment 
options and used 
according to 
patient’s choice
Mind body 
medicine 
techniques
Mindfulness 
meditation, 
autogenic  
training, 
progressive 
muscle relaxation, 
yoga, qigong
Acupressure and 
acupuncture
Acupressure:  
daily as self-care
Acupuncture:  
1×/week,  
6 weeks
3 Offered only to 
patients with 
severe CRF
Medication Methylphenidate, 
modafinil, 
corticosteroid, 
ginseng, guarana
chemotherapy that would have left her unable to perform 
acupressure.
Medication. The stakeholders agreed that medication should 
be the last level of the treatment program. They argued that 
patients “refuse to swallow more drugs than they already have 
to take.” A patient described the following feeling: “I could 
not bear to even see another pill [during chemotherapy], not to 
mention swallowing one.” Although the medical doctors and 
nurses noted that steroids and psychoactive drugs had short-
term effects on CRF in their patients, they also observed 
severe side effects. A medical doctor described these observa-
tions as follows: “Corticosteroids may have a good albeit 
short-lived effect in some patients. However, you are buying 
in a side effect through the back door.” The interviewed doc-
tors and nurses warned of possible interactions between the 
different drugs that are usually used during cancer therapy. In 
addition, they were critical of the existing clinical trials on the 
effects of all the proposed medications on CRF.
Integrative CRF Treatment Program After 
Stakeholder Engagement
Based on the presented stakeholder evaluation and its dis-
cussion among the stakeholder advisory board, the integra-
tive CRF treatment program was further developed. The 
most important issue seemed to be the adjustment of the 
program to the stakeholders’ wish to prioritize treatment 
options and include patient preferences and resources in 
treatment selection (see Table 3).
The stakeholders’ needs for prioritization was reflected 
in the new treatment program by clearly structuring the 
individual interventions into single steps in descending 
order of priority. The first level comprises providing infor-
mation to patients and caregivers about CRF and the poten-
tial benefit of exercise. Access to this basic information 
should be mandatory for all patients. Patients should be 
informed about the second level of options, which includes 
mind body medicine techniques, acupressure and acupunc-
ture that can be used according to patient preference. 
Medication (the third level) should be only used in cases of 
severe CRF.
To ensure awareness and widespread use of the program, 
all cancer patients should be at least screened for and 
informed about CRF.
Because of the stakeholders’ concerns about the possible 
stigma associated with the term “psychoeducation”, that 
intervention was renamed “information and motivation”.
From the Expert Version to the Stakeholder Version of the Inte-
grative CRF Treatment Program. In summary, starting with the 
expert version of the integrative CRF treatment program, 
which placed a number of treatment options on the same 
level, the new stakeholder version clearly prioritizes the 
interventions by introducing 3 different treatment levels, 
with level 2 taking patient preferences and resources into 
account (Figure 2).
Discussion
Overall, there was broad agreement among the interviewed 
stakeholders regarding their experiences and needs in rela-
tion to CRF and their opinion on the expert version of the 
integrative CRF treatment program. This agreement facili-
tated the further development of the treatment program and 
increased the probability that the program will be feasible 
and cover the needs of different stakeholder groups. 
Compared with the expert program, the stakeholder engage-
ment process first and foremost resulted in an emphasis on 
patient orientation on different levels: adjusting to the real-
life situation by prioritizing the individual treatment options 
and considering the resources and interests of the individual 
patients by offering a variety of treatment options at the sec-
ond level of priority.
The resulting stakeholder based integrative CRF treat-
ment program was implemented as clinical practice guide-
line at our clinic (Institute for Complementary and 
Integrative Medicine, University Hospital Zurich). The first 
experiences indicate that the program is very feasible in 
informing the patients about the treatment options as well as 
starting with a manageable treatment for the respective 
CRF patient.
Our approach had advantages and limitations. The 
advantages were the inclusion of a stakeholder advisory 
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board that included relevant stakeholder groups, the use of 
a stepwise systematic approach to develop the treatment 
model and the application of robust qualitative research 
methods. We conducted the stakeholder engagement mainly 
in the context of our hospital, which offered the advantage 
of developing a consistent model and a feasible program but 
had the limitation of possibly being too tailored and not 
applicable to other settings or health care systems. However, 
because a multimodal treatment program is best and is usu-
ally offered by a multiprofessional team, the setting of a 
hospital with outpatient services seems adequate. We did 
not interview health insurance workers and hospital admin-
istrators, who might have provided other insights. The par-
ticipating stakeholders based their statements on their own 
personal experiences and opinions, and a different group of 
stakeholders might have had different experiences.
We found the stakeholder engagement very helpful. In 
general, stakeholder engagement can help the people 
involved with CRF care make more informed health care 
decisions by identifying CRF as a critical and relevant 
research topic and by providing evidence-based informa-
tion about treatment options, which are discussed with the 
patient and adapted to their individual situation, needs and 
resources. This corresponds with the general goals and 
advantages of stakeholder engagement supported by the 
Patient-Centered Outcomes Research Institute (PCORI), 
which was authorized by the US Congress in 2010 and had 
a budget of approximately $400 million in 2016.27-29
We concluded that the stakeholders’ emphasis on priori-
tizing information, exercise, and mind body medicine tech-
niques corresponds with the current NCCN Clinical Practice 
Guidelines in Oncology for CRF.5 Whereas the guidelines 
also include bright white light therapy,5 our suggested treat-
ment program adds more CM interventions to the NCCN 
Guidelines; namely, qigong, acupressure, acupuncture, gin-
seng, and guarana. This inclusion corresponds to the needs 
and practice of approximately 40% of cancer patients, who 
wish to include CM in their cancer treatment.57
Challenges in the Implementation of the CRF 
Treatment Program
A major challenge in patient orientation is how the individ-
ual CRF patient can receive understandable, high-quality 
evidence-based information at the right moment. 
Stakeholders call for patients to be informed about CRF and 
treatment options soon after their diagnosis. The patients in 
the stakeholder group thought this information would be 
best provided by a drop-in center at the clinic that monitors 
and coordinates the treatment. The stakeholder advisory 
Figure 2. The expert and stakeholder versions of the integrative cancer-related fatigue (CRF) treatment program.
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board discussed the issue of the right time point for intro-
ducing information about CRF and suggested creating an 
online tool that patients can access after they learn about 
CRF from the health care provider. Everyone seemed to 
agree that information about CRF should be provided soon 
after a cancer diagnosis. The advisory board further noted 
the problem that in some places, cancer care is based in dif-
ferent departments, which makes it difficult to create a 
drop-in center for patients. The right time point for discuss-
ing CRF remains an open question that has also not been 
answered by the NCCN Clinical Practice Guidelines in 
Oncology for CRF.5 Considering that CRF is complex and 
highly dependent on the patient’s individual cancer progres-
sion, the NCCN Guideline for CRF suggest that every clinic 
or institution should work out a procedure for how to best 
inform patients depending on the institution’s structures and 
resources.5 Oncology nurses, who evaluated a former draft 
of the guidelines, noted that patients often do not report 
their symptoms to their health care providers because they 
do not want to complain in general and they fear that fatigue 
is a sign of progressive cancer.58 Based on this, the authors 
recommend addressing CRF in a discussion between 
patients and health care providers.58
Another major challenge is the apparent contradiction 
and incompatibility between suffering from fatigue and get-
ting active. It is hard for patients with CRF to overcome 
their exhaustion and find the motivation to exercise. The 
stakeholders suggested that this is best achieved when the 
CRF patients are guided or coached. This view is supported 
by current research, which found that supervised exercise 
has greater beneficial effects on CRF than exercise without 
supervision.59,60 Furthermore, the implementation of a 
supervised exercise program depends greatly on existing 
infrastructures and resources. Therefore, the stakeholder 
advisory board considered group programs or referrals to 
exercise specialists (eg, physical therapists) to be the most 
realistic intervention, but there is a lack of corresponding 
research to support or disprove the stakeholders’ opin-
ion.5,43,61 Thus, future research is needed to determine how 
best to develop an institutionalized individual or group 
exercise program for CRF patients that considers all the rel-
evant contextual factors, such as infrastructures, costs and 
resources.
A basic condition for mastering all the challenges in 
implementing such a treatment program is the need for edu-
cation and training programs in CRF management for health 
care providers in oncology. Furthermore, CRF treatment 
should be reimbursed by medical care contracts.5
Implications for Research and Practice
Further research should use quantitative methods to evalu-
ate the acceptance of this treatment model by a wider audi-
ence. As a next step in our clinic, the implemented 
integrative CRF treatment program should be scientifically 
evaluated. Ideally, further qualitative research that consid-
ers not only the improvement in CRF and quality of life but 
also addresses questions about context factors, such as cost-
effectiveness, infrastructure, and resources, should also be 
conducted.
Conclusion
Although CRF has gained increased attention in cancer 
research and treatment in the past decade, it remains preva-
lent and difficult to treat. The presented integrative treat-
ment program uses a multimodal approach that is structured 
into levels and combines effective conventional and CM 
treatments for CRF. By adopting a stakeholder engagement 
approach, we integrated the values, needs and preferences 
of people who are directly affected by or involved with CRF 
in the development of the treatment program to improve the 
quality, relevance, and feasibility of CRF treatment. 
Providing evidence-based information as an integral part of 
the treatment program will help the people affected by CRF 
to make informed health care decisions and potentially 
improve the health of the CRF patients. A qualitative 
research method approach was combined with stakeholder 
engagement to provide deep and rich insights into stake-
holders’ individual circumstances, needs, and values.
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